Literature DB >> 26109803

Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease.

Jian Wang1, Hao Du1, Ya-Ru Mou1, Jian-Yi Niu1, Wen-Tong Zhang1, Hong-Chao Yang1, Ai-Wu Li1.   

Abstract

AIM: To investigate the abundance and potential diagnostic significance of neuroligin-1 and glutamate (Glu) in Hirschsprung's disease (HSCR).
METHODS: Ninety children with HSCR and 50 children without HSCR matched for similar nutritional status, age and basal metabolic index were studied. The expression and localization of neuroligin-1 and Glu were assessed using double-labeling immunofluorescence staining of longitudinal muscles with adherent myenteric plexus from the surgically excised colon of children with HSCR. Western blot analysis, quantitative real-time PCR (qRT-PCR) and immunohistochemistry were performed to evaluate the abundance of neuroligin-1 and Glu in different HSCR-affected segments (ganglionic, transitional, and aganglionic segments). Enzyme-linked immunosorbent assay (ELISA) was used to detect and compare serum Glu levels in the long-segment HSCR, short-segment HSCR and non-HSCR samples.
RESULTS: Neuroligin-1 and Glu were co-expressed highest to lowest in the ganglionic, transitional and aganglionic segments based on Western blot (neuroligin-1: 0.177 ± 0.008 vs 0.101 ± 0.006, 0.177 ± 0.008 vs 0.035 ± 0.005, and 0.101 ± 0.006 vs 0.035 ± 0.005, P < 0.005; Glu: 0.198 ± 0.006 vs 0.115 ± 0.008, 0.198 ± 0.006 vs 0.040 ± 0.003, and 0.115 ± 0.008 vs 0.040 ± 0.003, P < 0.005) and qRT-PCR (neuroligin-1: 9.58 × 10(-5) ± 9.94 × 10(-6) vs 2.49 × 10(-5) ± 1.38 × 10(-6), 9.58 × 10(-5) ± 9.94 × 10(-6) vs 7.17 × 10(-6 ±) 1.12 × 10(-6), and 2.49 × 10(-5) ± 1.38 × 10(-6) vs 7.17 × 10(-6) ± 1.12 × 10(-6), P < 0.005). Serum Glu level was the highest to lowest in the non-HSCR, short-type HSCR and long-type HSCR samples based on ELISA (in nmol/μL, 0.93 ± 0.31 vs 0.57 ± 0.25, 0.93 ± 0.31 vs 0.23 ± 0.16, and 0.57 ± 0.25 vs 0.23 ± 0.16, P < 0.005).
CONCLUSION: Neuroligin-1 and Glu may represent new markers of ganglion cells, whose expression may correlate with the pathogenesis, diagnosis, differential diagnosis or classification of HSCR.

Entities:  

Keywords:  Ganglion cells; Glutamate; Hirschsprung’s disease; Neuroligin-1; Pathogenesis

Mesh:

Substances:

Year:  2015        PMID: 26109803      PMCID: PMC4476878          DOI: 10.3748/wjg.v21.i23.7172

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin.

Authors:  Oliver Prange; Tak Pan Wong; Kimberly Gerrow; Yu Tian Wang; Alaa El-Husseini
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

2.  The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?

Authors:  Margarita C Dinamarca; David Weinstein; Octavio Monasterio; Nibaldo C Inestrosa
Journal:  Biochemistry       Date:  2011-09-01       Impact factor: 3.162

Review 3.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

4.  The down-regulation of neuroligin-2 and the correlative clinical significance of serum GABA over-expression in Hirschsprung's disease.

Authors:  Hongchao Yang; Jianyi Niu; Jian Wang; Fan Zhang; Qiangye Zhang; Wentong Zhang; Aiwu Li
Journal:  Neurochem Res       Date:  2014-05-20       Impact factor: 3.996

Review 5.  Neuroimmune mechanisms in functional bowel disorders.

Authors:  M M Wouters; G E Boeckxstaens
Journal:  Neth J Med       Date:  2011-02       Impact factor: 1.422

6.  Congenital central hypoventilation syndrome with hirschsprung's disease due to PHOX2B gene mutation in a Turkish infant.

Authors:  Aytekin Kaymakçi; Fatma Narter; Ahmet Sami Yazar; Müberra Seğmen Yilmaz
Journal:  Turk J Pediatr       Date:  2012 Sep-Oct       Impact factor: 0.552

7.  Disturbances of colonic motility in mouse models of Hirschsprung's disease.

Authors:  Rachael R Roberts; Joel C Bornstein; Annette J Bergner; Heather M Young
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-14       Impact factor: 4.052

Review 8.  Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies.

Authors:  Tiffany A Heanue; Vassilis Pachnis
Journal:  Nat Rev Neurosci       Date:  2007-06       Impact factor: 34.870

9.  Calretinin immunohistochemistry: A new cost-effective and easy method for diagnosis of Hirschsprung's disease.

Authors:  Lavanya Kannaiyan; Sujani Madabhushi; Ramani Malleboyina; Narendra Kumar Are; K Ramesh Reddy; Bhuvaneshwar Rao
Journal:  J Indian Assoc Pediatr Surg       Date:  2013-04

10.  Expression and significance of neuroligins in myenteric cells of Cajal in Hirschsprung's disease.

Authors:  Jian Wang; Yaru Mou; Qiangye Zhang; Fan Zhang; Hongchao Yang; Wentong Zhang; Aiwu Li
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more
  3 in total

1.  Abundance and Significance of Neuroligin-1 and Neurexin II in the Enteric Nervous System of Embryonic Rats.

Authors:  Dongming Wang; Jingnian Pan; Guoxin Song; Ni Gao; Yi Zheng; Qiangye Zhang; Aiwu Li
Journal:  Biomed Res Int       Date:  2017-01-18       Impact factor: 3.411

2.  Role of GDNF, GFRα1 and GFAP in a Bifidobacterium-Intervention Induced Mouse Model of Intestinal Neuronal Dysplasia.

Authors:  Wei Liu; Tingting Zhou; Jinqiu Tian; Xiaofang Yu; Chuantao Ren; Zengcai Cao; Peimin Hou; Qiangye Zhang; Aiwu Li
Journal:  Front Pediatr       Date:  2022-01-14       Impact factor: 3.418

3.  Upregulated NLGN1 predicts poor survival in colorectal cancer.

Authors:  Qian Yu; Xiaojie Wang; Yinghong Yang; Pan Chi; Jianping Huang; Shengliang Qiu; Xin Zheng; Xiaowen Chen
Journal:  BMC Cancer       Date:  2021-08-02       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.